UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer

Cancer research (Chicago, Ill.), 2013-05, Vol.73 (9), p.2782-2794

2013

Volltextzugriff (PDF)

An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy

Cancer research (Chicago, Ill.), 2016-01, Vol.76 (1), p.73-82

2016

Volltextzugriff (PDF)

Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy

Cancer research (Chicago, Ill.), 2014, Vol.74 (1), p.153-161

2014

Volltextzugriff (PDF)

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

The Journal of clinical investigation, 2013-03, Vol.123 (3), p.1371-1381

2013

Volltextzugriff (PDF)

BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy

Cancer research (Chicago, Ill.), 2012-08, Vol.72 (16), p.3928-3937

2012

Volltextzugriff (PDF)

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

Clinical cancer research, 2011-06, Vol.17 (12), p.4101-4109

2011

Volltextzugriff (PDF)

Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses

Proceedings of the National Academy of Sciences - PNAS, 2010-08, Vol.107 (32), p.14286-14291

2010

Volltextzugriff (PDF)

Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines

Molecular cancer, 2012-04, Vol.11 (1), p.22-22, Article 22

2012

Volltextzugriff (PDF)

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

The Journal of clinical investigation, 2016-01, Vol.126 (1), p.402-403

2016

Volltextzugriff (PDF)

Abstract LB-399: Late interferon-gamma blockade improves antitumor efficacy of anti-CTLA-4 and anti-PD-1 combination treatment

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.LB-399-LB-399

2020

Volltextzugriff (PDF)

Abstract 662: Late CTLA-4 Ig treatment improves antitumor efficacy of immunotherapy

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.662-662

2022

Volltextzugriff (PDF)

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma

Science translational medicine, 2015-03, Vol.7 (279), p.279ra41

2015

Volltextzugriff (PDF)

Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma

Oncoimmunology, 2016-07, Vol.5 (7), p.e1052212-e1052212

2016

Volltextzugriff (PDF)

CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire

Clinical cancer research, 2014-05, Vol.20 (9), p.2424-2432

2014

Volltextzugriff (PDF)

Post-immunotherapy CTLA-4 Ig treatment improves antitumor efficacy

Proceedings of the National Academy of Sciences - PNAS, 2024-07, Vol.121 (27), p.e2404661121

2024

Volltextzugriff (PDF)

Abstract 2984: Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.2984-2984

2018

Volltextzugriff (PDF)

Blocking colony stimulating factor 1 receptor (CSF-1R) and tropomyosin receptor kinase A (TrkA) improves the antitumor efficacy of immune checkpoint blockade

The Journal of immunology (1950), 2018-05, Vol.200 (1_Supplement), p.122-122.15

2018

Volltextzugriff (PDF)

Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse

The Journal of immunology (1950), 2018-05, Vol.200 (1_Supplement), p.122-122.2

2018

Volltextzugriff (PDF)

Abstract A23: Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse

Cancer research (Chicago, Ill.), 2020-10, Vol.80 (19_Supplement), p.A23-A23

2020

Volltextzugriff (PDF)

Abstract 1685: Effects of anti-ctla-4 and anti-pd-1 on memory T-cell differentiation and resistance to tumor relapse

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1685-1685

2017

Volltextzugriff (PDF)

RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

The New England journal of medicine, 2012-01, Vol.366 (3), p.207-215

2012

Volltextzugriff (PDF)

Abstract A054: Anti-CTLA-4 generates memory T-cell with greater expansion and functionality than anti-PD-1

Cancer immunology research, 2023-12, Vol.11 (12_Supplement), p.A054-A054

2023

Volltextzugriff (PDF)

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

The Journal of clinical investigation, 2023-12, Vol.133 (24)

2023

Volltextzugriff (PDF)

Abstract 4149: Anti-CTLA-4 generates memory T-cells with greater expansion and functionality than anti-PD-1

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4149-4149

2023

Volltextzugriff (PDF)

Abstract 1354: Anti-CTLA-4 generates memory T-cells with greater expansion and functionality than anti-PD-1

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.1354-1354

2024

Volltextzugriff (PDF)

1 – 25 von 366

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(321)
Mit Volltextzugriff
(318)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer

An Effective Immuno-PET Imaging Method to Monitor CD8-Dependent Responses to Immunotherapy

Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

BRAF Inhibitor Vemurafenib Improves the Antitumor Activity of Adoptive Cell Immunotherapy

CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans

Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses

Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

Abstract LB-399: Late interferon-gamma blockade improves antitumor efficacy of anti-CTLA-4 and anti-PD-1 combination treatment

Abstract 662: Late CTLA-4 Ig treatment improves antitumor efficacy of immunotherapy

Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma

Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma

CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire

Post-immunotherapy CTLA-4 Ig treatment improves antitumor efficacy

Abstract 2984: Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse

Blocking colony stimulating factor 1 receptor (CSF-1R) and tropomyosin receptor kinase A (TrkA) improves the antitumor efficacy of immune checkpoint blockade

Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse

Abstract A23: Effects of anti-CTLA-4 and anti-PD-1 on memory T-cell differentiation and resistance to tumor relapse

Abstract 1685: Effects of anti-ctla-4 and anti-pd-1 on memory T-cell differentiation and resistance to tumor relapse

RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Abstract A054: Anti-CTLA-4 generates memory T-cell with greater expansion and functionality than anti-PD-1

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

Abstract 4149: Anti-CTLA-4 generates memory T-cells with greater expansion and functionality than anti-PD-1

Abstract 1354: Anti-CTLA-4 generates memory T-cells with greater expansion and functionality than anti-PD-1

Suchergebnisse filtern